title: [Chronic bronchitis].
abstract: Chronic bronchitis (CB) is diagnosed from symptoms. It is important for the diagnosis to distinguish from other diseases accompanying similar symptoms. Recently, some diseases such as diffuse panbronchiolitis (DPB) have been recognized to have some characteristics different from CB, which used to include these diseases. The pathogenesis of CB is mostly smoking and to quit smoking is the basic and most important therapy. Target of medication in CB consists of hypersecretion, airway limitation and infection. A 14-membered ring macrolide such as erythromycin has been found to be effective in some patients with CB.
authors.affiliation: Department of Medicine, Teikyo University School of Medicine.
authors.forename: M
authors.initials: M
authors.lastname: Nakajima
authors.forename: K
authors.initials: K
authors.lastname: Ohta
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001991:Bronchitis / Q000175:diagnosis / Q000628:therapy; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003937:Diagnosis, Differential; D018942:Macrolides; D010353:Patient Education as Topic; D012907:Smoking / Q000009:adverse effects; D016540:Smoking Cessation
chemical_list: D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D018942:Macrolides